Welcome to our cleanroom blog where we keep you informed on recent updates in our business and cleanroom industry insights and updates.
As our nation’s top scientists work tirelessly to develop a COVID-19 vaccine, the federal government, R&D groups and the pharmaceutical industry are working collaboratively to ensure our supply chain is ready to scale up production to meet the tremendous demand. Creating billions of doses of a COVID-19 vaccine is a herculean task.
A new wave of supply chain localization efforts are being fast tracked to offset the disruption caused by Covid-19
Taking care of ourselves and others in these difficult times – together we will persevere and grow stronger
The future holds increased regulation and heightened production standards for the medical marijuana, Cannabis and CBD industries.
The updated standard highlights that particular attention will be focused on the device materials used, rationale for biocompatibility tests performed, the compatibility of these materials with biological tissues, and the impact of the manufacturing processes on the material properties.
Gearing Up for EU MDR How cleanroom bioburden information can support biocompatibility assessments In medical device manufacturing, low bioburden levels are essential. We address EU MDR compliance from a bioburden and biocompatibility perspective for sterile medical...